Financials
- Market Capitalization 163.14 B
- Employee 17 K
- Founded 1987
- CEO Daniel O'Day
- Website www.gilead.com
- Headquarter Delaware, United States
- FIGI BBG000CKGBP2
- Industry Drug Manufacturers—General
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 44 | NVS Novartis AG | 153.39 USD | -0.43% | -2.39% | +0.18% | +26.31% | 292.69 B USD | ||
| 70 | AMGN Amgen Inc. - Common Stock | 360.45 USD | -0.81% | -3.70% | +1.46% | +21.28% | 194.54 B USD | ||
| 109 | PFE Pfizer, Inc. Common Stock | 24.48 USD | +1.20% | +1.79% | -6.78% | -3.36% | 139.52 B USD | ||
| 126 | BMY Bristol-Myers Squibb Company Common Stock | 59.37 USD | +3.14% | +2.73% | +4.16% | +25.68% | 121.24 B USD |
Frequently asked questions about Gilead Sciences, Inc. - Common Stock
What is the Gilead Sciences, Inc. - Common Stock stock price today?
The current price of Gilead Sciences, Inc. - Common Stock (GILD) is 131.4. Over the past 24 hours, the stock has changed by +1.21%. Follow the GILD chart for real-time price dynamics.
What is the stock ticker of Gilead Sciences, Inc. - Common Stock?
Gilead Sciences, Inc. - Common Stock trades under the ticker GILD. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Gilead Sciences, Inc. - Common Stock stock going up?
GILD has changed by -0.92% over the last week, +4.95% over the last month, and +18.35% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Gilead Sciences, Inc. - Common Stock release financial reports?
Yes. You can track Gilead Sciences, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Gilead Sciences, Inc. - Common Stock net income for the last quarter?
Gilead Sciences, Inc. - Common Stock reported net income of 2.02 B for the last quarter. The previous quarter showed 2.18 B, which means net income changed by -7.42%.
How many employees does Gilead Sciences, Inc. - Common Stock have?
As of the latest available data, Gilead Sciences, Inc. - Common Stock has 17 K employees. Workforce size can provide additional context about the company's scale and operations.
What is Gilead Sciences, Inc. - Common Stock EBITDA?
Gilead Sciences, Inc. - Common Stock EBITDA is 3.27 B, and its EBITDA margin is 47.05%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Gilead Sciences, Inc. - Common Stock stock?
You can buy Gilead Sciences, Inc. - Common Stock (GILD) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Gilead Sciences, Inc. - Common Stock stock?
Investing in Gilead Sciences, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the GILD chart and related analysis on metatrader.com as part of your research.